TScan Therapeutics, Inc.
TScan Therapeutics, Inc. scores highest on Earnings (49) and lowest on Nitro (15). Its PosiPenta is 33.86 out of 100, weaker than most similar companies.
On the Penta Grid this week, TScan Therapeutics, Inc. is Grid #698 of 837 in the Healthcare sector in United States, and Grid #3,379 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | 33.86 | 49 | 49 | 15 | 22 | 34 |
| Pasithea Therapeutics Corp. | 47.11 | 48 | 53 | 27 | 64 | 43 |
| Fractyl Health, Inc. | 13.27 | 0 | 34 | 5 | 3 | 24 |
| SeaStar Medical Holding Corporation | 31.68 | 19 | 28 | 43 | 37 | 32 |
| BioCardia, Inc. | 33.80 | 0 | 43 | 47 | 25 | 54 |
| HeartSciences Inc. | 28.03 | 0 | 38 | 61 | 1 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.25 |
| P/B ratio | 0.23 |
EEarnings
| Trailing EPS | ₹-86.19 |
| Forward EPS | ₹-54.22 |
NNitro
| Price | 21.88 |
| 52-week high | 243.42 |
| 52-week low | 19.04 |
| Fall from 52-week high | 91.0% |
TTorque
| Return on equity (ROE) | -95.81% |
| Debt-to-equity | 1.32 |
AAnchor
| Beta (price swings) | 1.14 |
| Market cap | ₹148 Cr |
| Insider holding | 1.76% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is TScan Therapeutics, Inc.'s PosiPenta score?
TScan Therapeutics, Inc.'s PosiPenta is 33.86 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does TScan Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, TScan Therapeutics, Inc. is Grid #698 of 837 in the Healthcare sector in United States, and Grid #3,379 of 4,000 in United States.
Which PosiPenta pillar is strongest for TScan Therapeutics, Inc.?
Earnings (growth), with a score of 49 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for TScan Therapeutics, Inc.?
Nitro (momentum), with a score of 15 out of 100: much weaker than most similar companies.
Has TScan Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 4.14 points, from 29.72 to 33.86.
PositoAI is for research and education only and is not investment advice.